These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 36602920)

  • 1. Glycemic Outcomes and Feature Set Engagement Among Real-Time Continuous Glucose Monitoring Users With Type 1 or Non-Insulin-Treated Type 2 Diabetes: Retrospective Analysis of Real-World Data.
    Dowd R; Jepson LH; Green CR; Norman GJ; Thomas R; Leone K
    JMIR Diabetes; 2023 Jan; 8():e43991. PubMed ID: 36602920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People with Type 1 Diabetes or Type 2 Diabetes Treated with Intensive Insulin Therapy.
    Nemlekar PM; Hannah KL; Green CR; Norman GJ
    Diabetes Ther; 2024 Mar; 15(3):639-648. PubMed ID: 38289464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation of Continuous Glucose Monitoring Is Linked to Improved Glycemic Control and Fewer Clinical Events in Type 1 and Type 2 Diabetes in the Veterans Health Administration.
    Reaven PD; Newell M; Rivas S; Zhou X; Norman GJ; Zhou JJ
    Diabetes Care; 2023 Apr; 46(4):854-863. PubMed ID: 36807492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Evidence and Glycemic Improvement Using Dexcom G6 Features.
    Akturk HK; Dowd R; Shankar K; Derdzinski M
    Diabetes Technol Ther; 2021 Mar; 23(S1):S21-S26. PubMed ID: 33434439
    [No Abstract]   [Full Text] [Related]  

  • 5. Real-World Continuous Glucose Monitoring Data from a Population with Type 1 Diabetes in South Korea: Nationwide Single-System Analysis.
    Kim JY; Jin SM; Andrade SB; Chen B; Kim JH
    Diabetes Technol Ther; 2024 Jun; 26(6):394-402. PubMed ID: 38277166
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of a Combined Continuous Glucose Monitoring-Digital Health Solution on Glucose Metrics and Self-Management Behavior for Adults With Type 2 Diabetes: Real-World, Observational Study.
    Kumbara AB; Iyer AK; Green CR; Jepson LH; Leone K; Layne JE; Shomali M
    JMIR Diabetes; 2023 Sep; 8():e47638. PubMed ID: 37590491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes.
    Dunn TC; Ajjan RA; Bergenstal RM; Xu Y
    Diabetes Technol Ther; 2024 Mar; 26(3):203-210. PubMed ID: 38444315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Improvements in Glycemic Control with Dexcom CGM Use in Adults with Noninsulin-Treated Type 2 Diabetes.
    Layne JE; Jepson LH; Carite AM; Parkin CG; Bergenstal RM
    Diabetes Technol Ther; 2024 Jun; ():. PubMed ID: 38904213
    [No Abstract]   [Full Text] [Related]  

  • 9. Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin Injections.
    Hallström S; Hirsch IB; Ekelund M; Sofizadeh S; Albrektsson H; Dahlqvist S; Svensson AM; Lind M
    Diabetes Technol Ther; 2021 Jun; 23(6):425-433. PubMed ID: 33416422
    [No Abstract]   [Full Text] [Related]  

  • 10. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
    Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
    Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada.
    Roze S; Isitt JJ; Smith-Palmer J; Lynch P
    Clinicoecon Outcomes Res; 2021; 13():717-725. PubMed ID: 34408456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in Diabetes-Related Hospitalizations and Medical Costs After Dexcom G6 Continuous Glucose Monitor Initiation in People with Type 2 Diabetes Using Intensive Insulin Therapy.
    Hannah KL; Nemlekar PM; Green CR; Norman GJ
    Adv Ther; 2024 Jun; 41(6):2299-2306. PubMed ID: 38619722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Real-Time Continuous Glucose Monitoring Data Sharing on Quality of Life and Health Outcomes in Adults with Type 1 Diabetes.
    Polonsky WH; Fortmann AL
    Diabetes Technol Ther; 2021 Mar; 23(3):195-202. PubMed ID: 32991199
    [No Abstract]   [Full Text] [Related]  

  • 14. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of glycemia in insulin resistance in youth with type 1 and type 2 diabetes.
    Chan CL; Pyle L; Morehead R; Baumgartner A; Cree-Green M; Nadeau KJ
    Pediatr Diabetes; 2017 Sep; 18(6):470-477. PubMed ID: 27503277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of continuous glucose monitoring for type 2 in diabetes management and research.
    Vigersky R; Shrivastav M
    J Diabetes Complications; 2017 Jan; 31(1):280-287. PubMed ID: 27818105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alarm Settings of Continuous Glucose Monitoring Systems and Associations to Glucose Outcomes in Type 1 Diabetes.
    Lin YK; Groat D; Chan O; Hung M; Sharma A; Varner MW; Gouripeddi R; Facelli JC; Fisher SJ
    J Endocr Soc; 2020 Jan; 4(1):bvz005. PubMed ID: 31993548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study.
    Gilbert TR; Noar A; Blalock O; Polonsky WH
    Diabetes Technol Ther; 2021 Mar; 23(S1):S35-S39. PubMed ID: 33470882
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
    Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Patterns of Continuous Glucose Monitoring Use and Metrics of Glycemic Control in Type 1 Diabetes and Type 2 Diabetes Patients in the Veterans Health Care System: Integrating Continuous Glucose Monitoring Device Data with Electronic Health Records Data.
    Okuno T; Macwan SA; Miller D; Norman GJ; Reaven P; Zhou JJ
    Diabetes Technol Ther; 2024 Jun; ():. PubMed ID: 38768417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.